Barron's Picks And Pans: Conagra, JPMorgan, L Brands, Weight Watchers And More
This weekend's Barron's cover story looks at why pharmaceutical giants are making big bets on gene therapy.
Other featured articles examine problems with packaged food companies and which high-yield dividends are safest.
Also, the prospects for a weight-loss products leader and a fashion retailer.
"Why Big Pharma Is Diving Into Gene Therapy" by Andrew Bary takes a look at what the likes of Crispr Therapeutics AG (NASDAQ: CRSP) and Editas Medicine Inc (NASDAQ: EDIT) have to offer to pharmaceutical giants.
In "Here's the Real Problem For Big Food Companies," Jack Hough shows how the issues with packaged food brands are much more complicated than just cost cutting. See what is and isn't working for Conagra Brands Inc (NYSE: CAG) and others.
Jack Hough's "What's Eating Weight Watchers Stock" find out what the CEO of Weight Watchers International, Inc. (NYSE: WTW) thinks are to blame for some of the company's woes. Don't cry for Oprah, says the article.
AbbVie Inc (NYSE: ABBV) and JPMorgan Chase & Co. (NYSE: JPM) are among the high-yielding stocks that top the ranks for dividend safety, according to "10 Stocks With Safe, Generous Dividends" by Lawrence C. Strauss.
In Ben Levisohn's "Battered L Brands Is Still Not a Buy," see why, even though L Brands Inc (NYSE: LB) said "everything is on the table" when it comes to rejuvenating the Victoria's Secret brand, that still might not be enough.
Also in this week's Barron's:
How to lower your bill next year
The single woman's guide to retirement planning
Whether budget deficits matter
Foldable phones as the next big thing
Whether sustainable investment returns will win over critics
See more from Benzinga
Insider Buys Of The Week: Kinder Morgan, Restaurant Brands, TransDigm
Benzinga's Bulls & Bears Of The Week: CBS, CVS, Fitbit, Kraft Heinz, Walmart And More
Barron's Picks And Pans: Apple, Altria, Micron Technology, Nvidia And More
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.